BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24300694)

  • 1. The glial perspective of autism spectrum disorders.
    Zeidán-Chuliá F; Salmina AB; Malinovskaya NA; Noda M; Verkhratsky A; Moreira JC
    Neurosci Biobehav Rev; 2014 Jan; 38():160-72. PubMed ID: 24300694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three hypotheses for developmental defects that may underlie some forms of autism spectrum disorder.
    Rubenstein JL
    Curr Opin Neurol; 2010 Apr; 23(2):118-23. PubMed ID: 20087182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neuroglia in autism spectrum disorders.
    Scuderi C; Verkhratsky A
    Prog Mol Biol Transl Sci; 2020; 173():301-330. PubMed ID: 32711814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroglia in Psychiatric Disorders.
    Scuderi C; Verkhratsky A; Parpura V; Li B
    Adv Neurobiol; 2021; 26():3-19. PubMed ID: 34888828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders.
    Herbert MR
    Curr Opin Neurol; 2010 Apr; 23(2):103-10. PubMed ID: 20087183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NG2 cells in the brain: a novel glial cell population.
    Nishiyama A
    Hum Cell; 2001 Mar; 14(1):77-82. PubMed ID: 11436356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pervasive developmental disorders: neurological perspectives].
    Tuchman RF
    Rev Neurol; 1996 Nov; 24(135):1446-50. PubMed ID: 8974753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychiatric disorders from a perspective of glia].
    Takebayashi M
    Seishin Shinkeigaku Zasshi; 2013; 115(12):1186-93. PubMed ID: 24601091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pervasive developmental disorders not otherwise specified. A developmental-psychopathological approach for the development of made-to-measure treatment planning.
    Verheij F; van Loon H
    Acta Paedopsychiatr; 1992; 55(4):235-42. PubMed ID: 1492555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the Interplay Between Neuron-Glia Cell Dysfunction and Glial Therapy in Autism Spectrum Disorder.
    Unnisa A; Greig NH; Kamal MA
    Curr Neuropharmacol; 2023; 21(3):547-559. PubMed ID: 36545725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
    Palmieri L; Papaleo V; Porcelli V; Scarcia P; Gaita L; Sacco R; Hager J; Rousseau F; Curatolo P; Manzi B; Militerni R; Bravaccio C; Trillo S; Schneider C; Melmed R; Elia M; Lenti C; Saccani M; Pascucci T; Puglisi-Allegra S; Reichelt KL; Persico AM
    Mol Psychiatry; 2010 Jan; 15(1):38-52. PubMed ID: 18607376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurobiology of lipid metabolism in autism spectrum disorders.
    Tamiji J; Crawford DA
    Neurosignals; 2010; 18(2):98-112. PubMed ID: 21346377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autism and other developmental brain disorders.
    Nat Med; 2009 May; 15(5):464. PubMed ID: 19424182
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroglia in neurodegeneration.
    Heneka MT; Rodríguez JJ; Verkhratsky A
    Brain Res Rev; 2010 May; 63(1-2):189-211. PubMed ID: 19944719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiological basis of autism.
    Silver WG; Rapin I
    Pediatr Clin North Am; 2012 Feb; 59(1):45-61, x. PubMed ID: 22284792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural methods used in rodent models of autism spectrum disorders: current standards and new developments.
    Wöhr M; Scattoni ML
    Behav Brain Res; 2013 Aug; 251():5-17. PubMed ID: 23769995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic abnormalities in autism: is there a rationale for selective nicotinic agonist interventions?
    Deutsch SI; Urbano MR; Neumann SA; Burket JA; Katz E
    Clin Neuropharmacol; 2010 May; 33(3):114-20. PubMed ID: 20190638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cells as sources and targets of natriuretic peptides.
    Prado J; Baltrons MA; Pifarré P; García A
    Neurochem Int; 2010 Nov; 57(4):367-74. PubMed ID: 20302900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting reactive astrogliosis by novel biotechnological strategies.
    Colangelo AM; Cirillo G; Lavitrano ML; Alberghina L; Papa M
    Biotechnol Adv; 2012; 30(1):261-71. PubMed ID: 21763415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of glial cells in schizophrenia: possible targets for therapeutic approaches.
    Takahashi N; Sakurai T
    Neurobiol Dis; 2013 May; 53():49-60. PubMed ID: 23146995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.